Bank of America Corporation (BAC) stock analysis: Buy

Bro's Verdict
Deep Dive

Rating

BUY

Confidence

72%

Target Price

$65.00

Upside

+19.6%

Horizon

medium

BAC trades at 11.92x NTM P/E, an 18% discount to its 2-year average, with +14.4% forward EPS growth and a PEG of ~0.83x, while the $5.07 revision series sits above the $4.56 headline consensus, suggesting understated earnings power. A re-rating to the historical 13.1x average implies ~$66.62, closely matching the consensus PT of $66.17 and the DCF range of $63–$67, supporting the $65 target. Key risks are NII compression from Fed cuts and credit normalization, but the scale-advantaged deposit franchise and potential buyback acceleration underpin the Buy.

Executive Summary

•BAC trades at 11.92x NTM P/E against a 2 year blended forward average of 13.1x, an 18% discount, while the consensus price target of $66.17 implies ~22% upside from $54.34.

•Forward EPS growth of +14.4% to $4.56 NTM is the key re rating driver, and the NTM EPS revision series sits higher at $5.07, suggesting consensus may be understating near term earnings power.

•Deposit repricing and Fed cut sensitivity are the swing factor for net interest income into 2027, with the market pricing a compression risk that appears overstated for a deposit franchise of this scale.

•Capital return capacity looks underappreciated: buyback acceleration is gated by the SCB outcome and Basel III endgame clarity, but would compound the EPS trajectory.

Financial Snapshot

•Revenue (TTM): $113.93b

•Revenue (NTM, consensus): $123.42b (+5.7% YoY)

•Net margin: 29.5%

•Operating margin: 38.3%

•ROE: 11.2%

•Market cap: $327.5b

•Q4 revenue: $31.56b, net income $8.75b

•Q3 revenue: $30.27b, net income $8.15b

•Q2 revenue: $28.37b, net income $7.32b

•Q1 revenue: $28.09b, net income $8.04b

•Quarterly EPS: Not disclosed

•Dividend yield: ~2.1%

•Net interest income: Not disclosed

•CET1 ratio: Not disclosed

•Net charge off rate: Not disclosed

Forward Outlook

•NTM revenue estimate: $123.42b, +5.7% YoY

•FY+2 revenue estimate: $130.50b, implying ~5.7% growth off the NTM base

•NTM EPS estimate: $4.56, +14.4% YoY

•FY+2 EPS estimate: $5.21, +14.3% off the NTM figure

•NTM EPS revision trend: $5.07 currently, above the $4.56 headline consensus, a positive divergence

•Net interest income trajectory: Not disclosed; deposit repricing is the primary lever into 2027

•Efficiency ratio: Not disclosed; management has flagged continued operating leverage and digital investment payoff

•Capital return: buyback pace dependent on SCB outcome and Basel III endgame finalisation

Valuation Analysis

•NTM P/E: 11.92x (forward)

•NTM P/S: 3.08x as reported (forward); cross check of $327.5b market cap on $123.42b NTM revenue implies ~2.7x, so treat the reported figure with caution

•NTM EV/EBIT: 7.6x blended forward vs 2 year average 28.8x (-0.7 SD)

•Blended forward P/E: 10.7x vs 2 year average 13.1x (-0.4 SD, -18% vs average)

•Blended forward EV/EBITDA: 7.4x vs 2 year average 23.5x (-1.0 SD)

•Blended forward EV/Revenue: 2.5x vs 2 year average 4.8x (-2.0 SD)

•LF P/BV: 1.4x vs 2 year average 0.9x (+1.8 SD, +55% vs average), the one metric trading rich

•Implied price at average blended forward P/E: $66.62

•Implied price at average LF P/BV: $35.11

•Consensus PT: $66.17, median $66, range $59 to $75

•Ratings: 35 Buy / 18 Hold / 1 Sell (consensus Buy)

•DCF fair value (WACC 9.5%, terminal growth 2.5%): ~$63 to $67, consistent with the P/E re rating case

•PEG on NTM: ~0.83x (11.92x P/E / 14.4% growth), attractive on a growth adjusted basis

Peer Comparison (TTM P/E)

•JPM: 14.4x TTM P/E, $894.6b market cap, premium franchise, best in class returns

•WFC: 12.0x TTM P/E, $248.7b market cap, turnaround and expense story

•C: 14.0x TTM P/E, $217.0b market cap, deep value and international optionality

•GS: 13.9x TTM P/E, $262.5b market cap, capital markets cyclicality

•BAC: 11.92x NTM P/E, a discount to all bulge bracket peers despite comparable scale

Key Risks & Catalysts

Risks

•Fed rate cuts compressing net interest income faster than deposit repricing can offset

•Commercial real estate exposure, particularly office, driving reserve build and credit costs

•Card and consumer net charge offs normalising above pre pandemic levels as savings buffers deplete

•Deposit competition raising funding costs and squeezing net interest margin

•Basel III endgame and SCB outcome constraining buyback capacity

•P/BV at +1.8 SD above its 2 year average leaves little room for execution missteps

•Expense inflation from technology and compliance investment pressuring the efficiency ratio

•13F holder count down sharply QoQ (-3,572) with 3,456 positions closed, signalling institutional rotation

Catalysts

•Q3 2026 results on 14 October 2026 as the near term re rating trigger

•Net interest income inflection if deposit repricing outpaces asset yield compression

•Buyback acceleration post SCB disclosure

•Investment banking and sales and trading recovery versus bulge bracket peers

•Efficiency ratio improvement as digital and tech investment scales

•Rate stabilisation or a shallower than feared cutting cycle

•Continued positive NTM EPS revisions above the $4.56 headline

Investment Thesis

BAC is a scale advantaged deposit franchise trading at a meaningful discount to both its own history and its bulge bracket peers. At 11.92x NTM P/E against a 13.1x 2 year average, and a PEG of ~0.83x, the market is pricing a pessimistic NII and credit outcome that the +14.4% forward EPS growth trajectory does not support. The divergence between the $4.56 headline NTM EPS and the $5.07 revision series suggests consensus is still catching up to the earnings power of the franchise.

The critical swing factor is net interest income. Deposit repricing sensitivity to Fed cuts is the single largest driver of the forward earnings path, and the market appears to be extrapolating the worst case. If deposit costs reprice lower faster than asset yields, NII stabilises and the efficiency ratio improves; a re rating to the historical average P/E of 13.1x implies $66.62, closely matching the consensus PT of $66.17 and the DCF range of ~$63 to $67. The one caution is valuation on book: P/BV at 1.4x sits +1.8 SD above its 2 year average, so the upside is an earnings and multiple story, not a deep value book story.

Capital return is the underappreciated leg: a favourable SCB outcome would unlock buyback acceleration, compounding the EPS trajectory. Credit quality, particularly CRE and card net charge offs, is the key risk to monitor, and deterioration there would invalidate the thesis quickly. Net, BAC is a Buy with a 12 month price target of $65, ~20% upside, anchored on a 13x NTM P/E applied to ~$5.00 of forward EPS, consistent with the $5.07 revision series.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Bank of America Corporation BAC

Bro's Verdict
Deep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's VerdictDeep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's Verdict
Deep Dive